We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

2% more funds holding

Funds holding: 283 → 288 (+5)

0.07% more ownership

Funds ownership: 94.92% → 94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$96.9M
2
FCM
Farallon Capital Management
California
+$27.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$19.4M
4
LP
LMR Partners
United Kingdom
+$18.5M
5
SGCM
Sand Grove Capital Management
United Kingdom
+$17.5M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$32.3M
2
PWAM
Park West Asset Management
California
-$29.6M
3
WP
Woodline Partners
California
-$19.5M
4
MAM
Melqart Asset Management
United Kingdom
-$18.9M
5
Boston Partners
Boston Partners
Massachusetts
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
76
Ameriprise
Minnesota
$4.15M -$593K -6,394 -12%
Adage Capital Partners
77
Adage Capital Partners
Massachusetts
$3.92M +$3.96M +42,664 New
CF
78
Corebridge Financial
Texas
$3.79M +$3.83M +41,271 New
Retirement Systems of Alabama
79
Retirement Systems of Alabama
Alabama
$3.7M -$65.1K -702 -2%
Allianz Asset Management
80
Allianz Asset Management
Germany
$3.68M +$4.92K +53 +0.1%
Balyasny Asset Management
81
Balyasny Asset Management
Illinois
$3.64M +$3.68M +39,609 New
HS
82
HighVista Strategies
Massachusetts
$3.6M – – –
SG Americas Securities
83
SG Americas Securities
New York
$3.52M +$1.05M +11,264 +42%
State Board of Administration of Florida Retirement System
84
State Board of Administration of Florida Retirement System
Florida
$3.34M -$187K -2,013 -5%
WAM
85
Wolverine Asset Management
Illinois
$3.19M -$37.1K -400 -1%
GI
86
GAMCO Investors
Connecticut
$2.95M +$55.4K +597 +2%
New York State Common Retirement Fund
87
New York State Common Retirement Fund
New York
$2.81M +$257K +2,773 +10%
LPL Financial
88
LPL Financial
California
$2.79M +$1.75M +18,817 +163%
BCC
89
Bridge City Capital
Oregon
$2.75M +$5.57K +60 +0.2%
New York State Teachers Retirement System (NYSTRS)
90
New York State Teachers Retirement System (NYSTRS)
New York
$2.73M -$445K -4,800 -14%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
91
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$2.5M +$2.41M +25,996 +2,159%
MS
92
Maven Securities
Jersey
$2.48M +$2.51M +27,018 New
BA
93
Bridgewater Associates
Connecticut
$2.48M -$241K -2,597 -9%
National Bank of Canada
94
National Bank of Canada
Quebec, Canada
$2.45M -$4.55M -49,005 -66%
Skandinaviska Enskilda Banken (SEB)
95
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.41M +$742K +8,000 +44%
CC
96
Centiva Capital
New York
$2.4M +$1.21M +13,065 +100%
Canada Life
97
Canada Life
Manitoba, Canada
$2.32M +$126K +1,359 +6%
QCM
98
Quantinno Capital Management
New York
$2.32M +$90K +970 +4%
DC
99
Diametric Capital
Massachusetts
$2.29M +$689K +7,423 +42%
CF
100
Cantor Fitzgerald
New York
$2.23M +$1.3M +14,043 +138%
2 3
4
5 6

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.